Molekulardiagnostik

PHOENIXDX® SARS-COV-2 MUTANT SCREEN [Q677H] is a real-time RT-PCR-based test system for the in vitro discrimination between wildtype SARS-CoV-2 and Q677H mutant SARS-CoV-2 in respiratory specimens and sera.

PHOENIXDX® SARS-COV-2 MUTANT SCREEN [T265I] is a real-time RT-PCR-based test system for the in vitro discrimination between wildtype SARS-CoV-2 and T265I mutant SARS-CoV-2 in respiratory specimens and sera.

PHOENIXDX® SARS-COV-2 MUTANT SCREEN [V1176F] is a real-time RT-PCR-based test system for the in vitro discrimination between wildtype SARS-CoV-2 and V1176F mutant SARS-CoV-2 in respiratory specimens and sera.

PHOENIXDX® SARS-COV-2 N501Y MULTIPLEX is a real-time RT-PCR-based diagnostic test for the in vitro qualitative detection and discrimination of SARS-CoV-2 and the N501Y mutant in respiratory specimens and sera from patients who meet COVID-19 clinical and/or epidemiological criteria.

PHOENIXDX® COVID-19 VOC 4-PLEX A is a real-time RT-PCR-based diagnostic test for the in vitro qualitative detection and discrimination of SARS-CoV-2 mutations E484K, K, Deletion HV69/70, K417N and P681H in respiratory specimens and sera from patients who meet COVID-19 clinical and/or epidemiological criteria.

real-time RT-PCR-based diagnostic test for the in vitro qualitative detection and discrimination of SARS-CoV-2, Delta and Omicron.

Adellgene Fragile X Screening is a diagnostic kit designed for use in laboratories, which detects the number of CGG triplet repeats (cytosine-guanine-guanine) in the 5’ untranslated region of the gene for fragile X mental retardation (“Fragile X mental retardation-1”: FMR1). It aims to aid diagnosis of the clinical disease associated with Fragile X syndrome, for example, mental retardation, primary ovarian failure, and tremors / ataxia.